Related Experiment Video
Updated: Nov 1, 2025

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method
Published on: July 4, 2021
A study of hyperhomocysteinemia in cerebral venous sinus thrombosis
Jayantee Kalita1, Varun K Singh1, Usha Kant Misra1
1Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Insights
Hyperhomocysteinemia is a significant, treatable risk factor for cerebral venous sinus thrombosis (CVST), particularly in Indian populations. Many patients have low vitamin B12 or MTHFR mutations, highlighting key areas for intervention.
Area of Science:
- Neurology
- Thrombosis Research
- Nutritional Biochemistry
Background:
- Vegetarian diets can lead to vitamin B12 deficiency and hyperhomocysteinemia.
- Hyperhomocysteinemia is linked to thrombotic conditions like cerebral venous sinus thrombosis (CVST).
- Limited data exists on the clinico-radiological presentation and outcomes of hyperhomocysteinemic CVST patients.
Purpose of the Study:
- To investigate the relationship between homocysteine (Hcy), vitamin B12, folic acid, and MTHFR mutations in CVST patients.
- To compare the clinical and radiological severity and outcomes of CVST patients with and without hyperhomocysteinemia.
Main Methods:
- Included 96 CVST patients with measured Hcy levels.
- Assessed risk factors, neurological status, and MR imaging/venography findings.
- Evaluated prothrombotic conditions: Hcy, vitamin B12, folic acid, and MTHFR 677C→T mutation; outcomes assessed at 3 months.
Main Results:
- Hyperhomocysteinemia was present in 52.1% of patients; 32% had no other identified thrombotic cause.
- Patients with hyperhomocysteinemia showed higher rates of vitamin B12 deficiency (70% vs. 13%) and MTHFR 677C→T mutation (47.5% vs. 9.1%).
- Clinico-radiological severity and 3-month outcomes were similar between hyperhomocysteinemic and normohomocysteinemic groups.
Conclusions:
- Hyperhomocysteinemia is a crucial, modifiable risk factor for CVST in Northern Indian patients.
- Low vitamin B12 levels or MTHFR mutations were common in hyperhomocysteinemic CVST patients.
- Early detection and management of hyperhomocysteinemia are vital for CVST prevention and treatment.
Background & Objectives:
Vegetarianism may result in low vitamin B12 and acquired hyperhomocysteinemia leading to thrombotic conditions such as cerebral venous sinus thrombosis (CVST). The clinico-radiological presentation and outcome of patients with hyperhomocysteinemia may be different from those without, but there is a paucity of information. This study was undertaken to find out the relationship of homocysteine (Hcy) with vitamin B12, folic acid and methyltetrahydrofolate reductase (MTHFR) mutation in the patients with CVST, and compare clinico-radiological severity and outcome of patients with and without hyperhomocysteinemia.
Methods:
Ninety-six CVST patients in whom Hcy level was measured, were included, and their risk factors and neurological, magnetic resonance (MR) imaging and MR venography findings were noted. They were evaluated for prothrombotic conditions including Hcy, vitamin B12, folic acid and MTHFR 677C→T mutation. Three month outcome was categorized as death, poor and good.
Results:
Seventy three per cent patients had risk factors; hyperhomocysteinemia in 52.1 per cent, protein S deficiency in 47.8 per cent, protein C deficiency in 19.4 per cent, MTHFR 677C→T mutation in 30.7 per cent, antinuclear antibody 11 per cent, and Factor V Leiden mutation in two per cent each. Thirty two per cent patients with hyperhomocysteinemia had no other thrombotic cause, and 22 per cent of them had either vitamin B12 and or folic acid deficiency only. The patients with hyperhomocysteinemia more frequently had vitamin B12 deficiency (70 vs. 13%), MTHFR 677C→T mutation (47.5 vs. 9.1%) and superior sagittal sinus thrombosis (78 vs. 56.5%) than normal Hcy group. The clinico-radiological severity and outcome were similar.
Interpretation & Conclusions:
Hyperhomocysteinemia was an important correctable risk factor of CVST in patients from northern India, and majority of them had either low vitamin B12 level or MTHFR mutation.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

